Pages that link to "Q28533482"

The following pages link to Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition (Q28533482):

Displaying 12 items.

• Inhibitor ranking through QM based chelation calculations for virtual screening of HIV-1 RNase H inhibition (Q28539353) (← links)
• The biology and synthesis of α-hydroxytropolones (Q33968209) (← links)
• Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones (Q35302819) (← links)
• Discovery of new [Formula: see text] proteasome inhibitors using a knowledge-based computational screening approach (Q35732424) (← links)
• Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development (Q38250453) (← links)
• Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking. (Q38640162) (← links)
• Binding free energy based structural dynamics analysis of HIV-1 RT RNase H-inhibitor complexes (Q42200176) (← links)
• In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid protein (Q47240941) (← links)
• Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery (Q56700832) (← links)
• Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening (Q57712447) (← links)
• Structure-guided approach identifies a novel class of HIV-1 ribonuclease H inhibitors: binding mode insights through magnesium complexation and site-directed mutagenesis studies (Q58196866) (← links)
• 3-Hydroxypyrimidine-2, 4-dione Derivatives as HIV Reverse Transcriptase-Associated RNase H Inhibitors: QSAR Analysis and Molecular Docking Studies (Q99405064) (← links)